17 March 2023 : Clinical Research
Prospective Safety Evaluation of the Femtosecond Laser-Assisted Keratomileusis Procedure in Correcting Residual Ametropia in Patients After Deep Anterior Lamellar Keratoplasty
Dominika Janiszewska-Bil123ABCDEF*, Barbara Czarnota-Nowakowska4ABDE, Katarzyna Krysik13E, Magdalena Mistarz15E, Dariusz Dobrowolski367CD, Beniamin Oskar Grabarek15EF, Anita Lyssek-boroń138CEDOI: 10.12659/MSM.939691
Med Sci Monit 2023; 29:e939691
Table 3 Changes in the UCVA and BCVA values in patients of the study and comparison groups before and after Femto-LASIK procedure.
| Parameter | Group | 0 months | 3 months | 6 months | 12 months | 24 months | p-value1 | p-value2 |
|---|---|---|---|---|---|---|---|---|
| UCVA | Study | 0.1±0.05 | 0.7±0.05 | 0.7±0.05 | 0.7±0.05 | 0.7±0.05 | <0.001 | 0.021 |
| Comparison | 0.2±0.05 | 1.0±0.05 | 1.0±0.04 | 1.0±0.05 | 1.0±0.05 | <0.001 | ||
| BCVA | Study | 0.75±0.05 | 0.8±0.05 | 0.8±0.05 | 0.75±0.05 | 0.75±0.05 | >0.05 | 0.076 |
| Comparison | 1.1±0.05 | 1.1±0.05 | 1.1±0.05 | 1.1±0.05 | 1.1±0.05 | >0.05 | ||
| Data presented are mean±standard deviation; UCVA – uncorrected vision acuity; BCVA – best-corrected vision acuity; value – statistically significant differences between groups by one-way ANOVA; value – statistically significant differences between groups by the two-factor ANOVA. | ||||||||